Evidence map›Paper›PMID 41842894›Full record

ArticleJAMA network open2026

Violence Against Women Who Inject Drugs.

Samantha Colledge-Frisby, Shelly Walker, Anna Lee Wilkinson, Bek Petrovic, Lisa Maher, Daisy Gibbs, Gail Gilchrist, Sophia Schroeder, Amanda Roxburgh, Marika Burgess and 10 more

Abstract read
In one paragraph

Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Samantha Colledge-FrisbyNational Drug Research Institute, Curtin University, Melbourne, Australia.
Shelly WalkerNational Drug Research Institute, Curtin University, Melbourne, Australia.
Anna Lee WilkinsonDisease Elimination, Burnet Institute, Melbourne, Australia.
Bek PetrovicDisease Elimination, Burnet Institute, Melbourne, Australia.
Lisa MaherDisease Elimination, Burnet Institute, Melbourne, Australia.
Daisy GibbsDisease Elimination, Burnet Institute, Melbourne, Australia.
Gail GilchristNational Addiction Centre, King's College London, London, United Kingdom.
Sophia SchroederDisease Elimination, Burnet Institute, Melbourne, Australia.
Amanda RoxburghDisease Elimination, Burnet Institute, Melbourne, Australia.
Marika BurgessDisease Elimination, Burnet Institute, Melbourne, Australia.
Peter HiggsDisease Elimination, Burnet Institute, Melbourne, Australia.
Sione CrawfordHarm Reduction Victoria, Melbourne, Victoria, Australia.
Nadia GavinHarm Reduction Victoria, Melbourne, Victoria, Australia.
Paul AgiusDisease Elimination, Burnet Institute, Melbourne, Australia.
Bernadette WardDisease Elimination, Burnet Institute, Melbourne, Australia.
Joseph DoyleDisease Elimination, Burnet Institute, Melbourne, Australia.
Nico ClarkDisease Elimination, Burnet Institute, Melbourne, Australia.
Mark StoovéDisease Elimination, Burnet Institute, Melbourne, Australia.
Paul DietzeNational Drug Research Institute, Curtin University, Melbourne, Australia.
Ashleigh Cara StewartNational Drug Research Institute, Curtin University, Melbourne, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Women who inject drugs disproportionately report experiencing violence, yet they are overlooked in interventions and policy responses. Objective: To quantify and contextualize experiences of violence among Australian women who inject drugs. Design, Setting, and Participants: This mixed-methods cohort study used data from SuperMIX, a longitudinal cohort of people who inject drugs. Self-reported survey data from January 1, 2008, to December 31, 2019, were linked with administrative health records (hospital, emergency department, ambulance, and mortality). Qualitative interviews with 10 women between October 1 and November 30, 2023, explored experiences of violence and service access. Women were recruited via convenience sampling carried out across Melbourne, Australia, in areas with known drug markets and needle and syringe programs. Statistical analysis was performed between May and August 2025. Main Outcomes and Measures: Experience of assault or violence. Results: A total of 431 women were included, with a median age at baseline of 29 years (IQR, 25-34 years). By 2019, combining self-report and administrative data, 353 women (82% [95% CI, 78%-86%]) had experienced at least 1 assault, and 164 (38% [95% CI, 36%-43%]) had experienced at least 1 sexual assault. In administrative data, 82 of the 431 women (19% [95% CI, 15%-23%]) had ever had an assault-related hospital admission, 101 (23% [95% CI, 19%-27%]) had an assault-related emergency department presentation, and 74 (17% [95% CI, 14%-21%]) had an assault-related ambulance attendance. A total of 304 women (71%) completed at least 1 annual follow-up survey (total, 1677 follow-up surveys), of whom 178 (59% [95% CI, 53%-64%]) reported an assault since their last interview. Among 409 follow-up surveys reporting assault, seeking health care was reported in approximately one-third (128 [31%]). Qualitative findings revealed barriers to seeking health care, including stigma, fear of child protection involvement, lack of trust in clinicians, and logistical challenges. Conclusions and Relevance: In this mixed-methods cohort study of Australian women who inject drugs, violence against women was pervasive and severe, yet rates of seeking health care remained low likely due to intersecting structural and social barriers. Recognition of the burden of violence is a critical first step in ensuring tailored responses to violence that meet the needs of marginalized women.

Indexed as

Substance Abuse, IntravenousViolenceAdultAustraliaCohort StudiesFemaleHumansLongitudinal Studies

Identifiers

PMID41842894
PMCPMC13446803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.